Segment Information

9 Months Ended

Apr. 30, 2013

Segment Information

12. Segment Information:

We have three reportable segments: Medical Imaging, Ultrasound, and Security Technology. Our Medical Imaging segment consists primarily of systems and subsystems used in CT and MRI medical imaging equipment and direct conversion digital x-ray detectors for mammography sold primarily through OEM customers. Our Ultrasound segment consists of ultrasound systems and transducers for the urology, ultrasound-guided surgery and point of care markets sold primarily through our direct sales force and ultrasound transducers sold primarily through OEM customers. Our Security Technology segment consists of advanced threat detection aviation security systems and subsystems sold primarily through OEM customers.

Net revenue, income from operations, identifiable assets, share-based compensation expense, and depreciation and amortization expense of our reportable segments were as follows:

	Three Months Ended April 30,					Nine Months Ended April 30,
	2013			2012		2013			2012
Net revenue:
Medical Imaging	$	71,634		$	72,760	$	228,310		$	220,697
Ultrasound		33,990			33,889		106,134			109,568
Security Technology		20,141			14,621		49,742			35,295
Total	$	125,765		$	121,270	$	384,186		$	365,560
	Three Months Ended April 30,					Nine Months Ended April 30,
	2013			2012		2013			2012
Income (loss) from operations before income taxes:
Medical Imaging (A)	$	6,506		$	4,847	$	22,440		$	12,859
Ultrasound (B)		(4,422	)		2,350		(1,689	)		6,713
Security Technology (C)		4,628			2,676		7,199			3,676
Total income from operations		6,712			9,873		27,950			23,248
Total other (expense) income, net (D)		190			423		(1,118	)		3,689
Total	$	6,902		$	10,296	$	26,832		$	26,937

(A) Includes $2,198 of contingent consulting fees related to the tax refund and related interest received in the nine months ended April 30, 2012.

(B) Includes the operating results following our acquisition of Ultrasonix on March 2, 2013 as discussed in Note 3 and $496 of restructuring charges related to our Ultrasonix manufacturing consolidation as discussed in Note 8.

(C) Includes $516 of contingent consulting fees related to the tax refund and related interest received in the nine months ended April 30, 2012.

(D) Includes a gain of $2,500 from the sale of our remaining interest in our China based affiliate received in the nine months ended April 30, 2012.

	As of
	April 30, 2013		July 31, 2012
Identifiable assets:
Medical Imaging (E)	$	209,400	$	199,512
Ultrasound (F)		225,986		136,388
Security Technology		39,199		26,769
Total reportable segment assets		474,585		362,669
Corporate assets (G)		92,024		195,327
Total	$	566,609	$	557,996

(E) Includes goodwill of $1,849 relating to our 2008 acquisition of Copley Controls.

(F) Includes $48,380 of goodwill relating to our acquisition of Ultrasonix. See Note 3 for further information in regards to the acquisition of Ultrasonix.

(G) Includes cash and cash equivalents of $43,455 and $153,122 at April 30, 2013 and July 31, 2012, respectively. The decrease in cash and cash equivalents is primarily due to our recent acquisition of Ultrasonix. See Note 3 for further information in regards to the acquisition of Ultrasonix.

	Three Months Ended April 30,				Nine Months Ended April 30,
	2013		2012		2013		2012
Share-based compensation:
Medical Imaging	$	1,180	$	1,441	$	4,861	$	4,852
Ultrasound		442		490		1,620		1,606
Security Technology		382		384		1,476		1,258
Total	$	2,004	$	2,315	$	7,957	$	7,716
Depreciation and amortization:
Medical Imaging	$	2,723	$	2,858	$	8,213	$	8,700
Ultrasound		1,458		1,310		3,388		4,153
Security Technology		312		278		936		876
Total	$	4,493	$	4,446	$	12,537	$	13,729